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Abstract 
Objective 
The melanocortin 4 receptor gene (MC4R) is involved in body weight regulation. 
While many studies associated MC4R mutations with childhood obesity, information 
on MC4R mutations in Spanish children and adolescents is lacking. Our objective was 
to screen a population of children and adolescents from the north of Spain (Navarra) 
for MC4R mutations and to study the phenotypes of carriers and their families. In 
addition, functional assays were performed for a novel MC4R mutation. 
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Methods 
The study was comprised of 451 Spanish children and adolescents (49% boys), aged 
5-18 year. According to the International Obesity Task Force (IOTF) criteria, the 
groups included 160 obese, 132 overweight and 159 normal-weight control subjects.  
Results 
One novel (Thr162Arg) and three known non synonymous mutations in the MC4R 
gene (Ser30Phe, Thr150Ile, Ala244Glu) were detected heterozygously. The MC4R 
mutations were found in three male (one obese and two overweight) and two female 
subjects (one obese and one overweight). The novel mutation did not appear to lead to 
an impaired receptor function. An unequivocal relationship of MC4R mutations with 
obesity in pedigrees together with an impaired function of the encoded receptor could 
not be established for any of the mutations. 
Conclusions 
The presence of heterozygous MC4R mutations in obese and overweight subjects 
indicates that these mutations may be a susceptibility factor for obesity development, 
but lifestyle factors, such as exercise or sedentary activities, may modify their effect. 
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Introduction 
  
The melanocortin 4 receptor (MC4R) exerts an important role in controlling food 
intake in humans. Since 1998, investigators have reported at least 72 mutations in the 
MC4R gene 1  and an impaired MC4R function seems to induce severe obesity soon 
after birth 2 . MC4R mutations are more frequent in northern European populations as 
compared to Mediterranean or Asian populations; its prevalence ranges from 0.5% to 
6% 2 . Currently, a total of 91 mutation carriers have been reported in 3057 children 
and adolescent subjects, most of them heterozygotes, which represents 2.98% of 
childhood-onset obesity 3 . 
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Although there is a consensus that MC4R mutations may excert a monogenic effect on 
extreme obesity, the direct involvement of MC4R mutations in causing obesity has 
been questioned by studies that have detected low-frequency mutations in adult 
control subjects. Marti et al. 4  and Jacobson et al. 5  reported two normal-weight 
subjects carrying mutations that encoded partially active receptors 6 . Hinney et al. 1  
found six non-obese carriers of MC4R mutations with impaired receptor function in 
vitro. Thus, it is worth mentioning that the loss of MC4R function in vitro does not 
necessarily lead to obesity. 
 
Furthermore, a number of studies have revealed discrepancies among investigators on 
the effect of a given mutation on obesity development, which may be partially 
explained by environmental influences. Lifestyle factors, especially those related to 
diet and physical or sedentary activities, can interact with genetic factors and may 
mask genotype influences 7, 8 . Our objective was to examine a children and adolescent 
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population (obese, overweight and normal-weight subjects) from the north of Spain 
(Navarra) for mutations in the MC4R gene and to test the relevance of family history 
of obesity. The sedentary and physical activities of all subjects were carefully 
examined. A functional characterization of a novel mutation of the MC4R gene was 
also performed. 
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Materials and methods 
 
The study population, recruited from the pediatric departments of two hospitals and 
three community health centres, was composed of 451 Spanish children and 
adolescents (49% boys), aged 5-18 years. Obesity was defined according to Cole et al. 
9 . Thus, the study group included 160 obese, 132 overweight, and 159 normal weight 
individuals. Non-obese participants were healthy subjects coming to the community 
health centres for routine medical examination or to be vaccinated. Eighty-three per 
cent of obese subjects were recruited through the hospitals, whereas 62% of 
overweight participants attended the health centres. Exclusion criteria were (i) 
exposure to hormonal treatment or ii) development of secondary obesity due to an 
endocrine disorder or other illness. Ethical approval was granted by the Ethics 
Committee of the University of Navarra. All parents and subjects who are 12 years of 
age or older provided written informed consent, whereas children younger than 12 
years gave verbal consent to participate in the study. The reported investigation was 
carried out according to the Declaration of Helsinki II principles.  
Anthropometric measurements were made by standard procedures and fat mass was 
measured by bioelectrical impedance (TBF-300 A Body Composition Analyzer/Scale, 
TANITA©, Tokyo, Japan). Following a 12-h fast, venous blood samples were 
obtained and serum glucose, lipids, insulin, cortisol and leptin were determined for 
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93% of the subjects. Trained researchers conducted face-to-face interviews and helped 
80% of the participants and their parents fill out questionnaires. A recently validated 
physical activity questionnaire – the Spanish version of the physical activity 
questionnaire used in the Nurses’ Health Study and the Health Professionals’ Follow-
up Study – was used.
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11 . It included 17 activities and sports and nine option responses 
for frequency, ranging from “never” to “11 or more hours per week”. A multiple of 
resting metabolic rate (MET score) was assigned to each activity. With this 
information, we computed an activity metabolic equivalent index (METs hours/week), 
which represents the amount of weekly leisure physical exercise for each participant 
12, 13 . The sedentary activities were computed through questions pertained to time 
spent watching TV, playing computer or video games, reading, and sleeping during 
the day. In order to assess for hyperphagia, participants were asked to rate their 
appetite from 1 to 5.  
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Blood samples were taken for extraction and characterization of genomic DNA from 
leucocytes. Single strand conformational polymorphism (SSCP) screening for 
mutations in the MC4R gene was performed as previously described 14 . PCR products 
of samples with aberrant SSCP pattern were resequenced to identify specific 
nucleotide changes. For the unambiguous assignment of the genotypes, allele 
discrimination was made independently by at least two experienced researchers. 
Discrepancies were solved by repeating.  
Family members of pedigrees, including carriers of mis-sense mutations, were asked 
to participate in the study. Anthropometric measurements were obtained and face-to-
face interviews were conducted with each family member. The questionnaire included 
8 questions about physical activity and 11 questions about binge eating disorder 
(BED), based on diagnostic criteria of the DSM-IV 15 . A “BED score” was calculated 
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ranging from 0 to 11 based on the number of positive answers to the DSM-IV 
questionnaire. Blood samples from volunteer family members were drawn for 
genotyping. 
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Functional characterization of the Thr162Arg mutant MC4R 
The novel mutant MC4R identified in this study (Thr162Arg) and the wild-type  
MC4R were cloned in a pcDps expression vector. For functional studies, mutant and 
wild-type receptors were transiently transfected into COS-7 cells using Metafectene 
(Biotex, Munich, Germany) according to the manufacturer´s protocol. To investigate 
signal transduction properties, cells were labelled with 2 µCi/ml of [3H]adenine 
(Amersham, Little Chalfont, UK) 72 hours after transfection. One day later, Cyclic 
AMP (cAMP) accumulation assays were performed. Cells were stimulated with 
increasing concentrations of α-melanocyte stimulating hormone (α-MSH), its potent 
analog, [Nle[4], D-Phe[7]]-α-MSH (NDP-MSH), or β-MSH; cAMP-assays were 
performed as described elsewhere.16. Cyclic AMP accumulation data were analysed 
using GraphPad Prism (GraphPad Software, San Diego, CA, USA). All data of the 
functional study were obtained from at least five independent experiments.  
To investigate cell surface expression, MC4R wild-tupe and Thr162Arg mutant were 
N-terminally HA-tagged and cell surface ELISA studies were performed. In brief, 72 
h after transfection, cells were washed two times with Dulbecco’s phosphate buffered 
saline (DPBS) and fixed for 30 min in 4% formaldehyde in DPBS followed by two 
times washing in DPBS. Cells were then incubated in blocking buffer (10% fetal calf 
serum-supplemented Dulbecco`s minimal essential medium) for 1 h at 37°C followed 
by a washing step in DPBS and a 2-h incubation in blocking buffer with 1 µg/ml 
biotin labelled anti-HA monoclonal antibody (Roche) at 37°C. After three washes in 
20 
25 
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DPBS, cells were incubated in blocking buffer with 1:5000 diluted streptavidin 
labelled peroxidase (Dianova, Hamburg, Germany) at 37°C for 1 h followed by three 
times washing . The colour reaction was carried out in a buffer containing 0.1% H O2 2 
and 10 mg o-phenylendiamine in 0.1 M citric acid and 0.1 M Na5 
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HPO2 4 at pH 5.2. The 
reaction was stopped after 10 min with 1M Na SO2 3 in 1M HCl. Colorimetry was 
carried out using an Anthos reader 2001 (Anthos Labtech Instruments, Salzburg, 
Austria). The data of cell expression were calculated from 10 independent 
experiments. 
 
Results 
 
One novel and three known nonsynonymous mutations in the MC4R gene were 
detected heterozygously in two girls and three boys from a total of 451 (49 % boys) 
children and adolescents from a Navarra population group (Table 1). A synonymous 
variation has also been found in an obese child. Two children were heterozygous for 
the Val103Ile polymorphism (1 obese and 1 overweight) and 11 subjects carried the 
Ile251Leu polymorphism heterozygously (two obese, three overweight and six 
normal-weight subjects). 
 
The prevalence of nonsynonymous mutations was 1.2% in the obese group and 2.3% 
in the overweight group. Phenotypic characteristics of participants (carriers and non-
carriers of MC4R mutations) are summarized in Table 2. Information on physical and 
sedentary activities is also detailed. The obese and overweight study groups showed 
lower levels of physical activity as measured by metabolic equivalents (METs 
hours/week) than the normal weight subjects (37.3 and 27.6 respectively, vs. 18.2 
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METs hours/week). The differences were statistically significant (p<0.001, Kruskal-
Wallis test). Moreover, normal-weight subjects spent less time engaging in sedentary 
activities (16.8 h/week vs. 17.0 h/week for the overweight group and 19.6 h/week for 
the obese group; p=0.019) than obese or overweight subjects. In Fig. 1a, a summary of 
the information regarding MC4R mutation carriers and their families is presented.  
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Finally, we evaluated binge eating disorder (DSM-IV 15  in MC4R mutation carriers. 
None of these individuals fulfilled the DSM-IV criteria for BED. There was no 
statistically significant difference for BED score between carriers and noncarriers of 
MC4R mutations (Fig. 1). Hyperphagia was also evaluated with the aid of a scale 
ranging from 1 to 5. As seen in Table 2, four out of six MC4R mutation carriers 
showed high levels of hyperphagia (score of 5).  
 
Discussion 
 
One novel (Thr162Arg) and three known (Ser30Phe, Thr150Ile, Ala244Glu) non-
synonymous mutations in the MC4R gene were detected heterozygously by screening 
of 451 Spanish children and adolescents (49% boys). MC4R mutations were found in 
three male (one obese and two overweight) and two female subjects (one obese and 
one overweight). Differences in mutation frequency or obesity degree were not 
attributed to sex. However, previously, in a family–based setting, Dempfle et al. 17  
found that MC4R mutation allele effects on BMI were stronger in females compared 
to males. 
 
The prevalence of MC4R mutations was 1.7% in the obese and overweight groups of 
the Spanish children and adolescents. In the so far only study on MC4R mutations in 
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Spanish adults the frequency was 0.6% 4 . Similarly, lower values of prevalence for 
MC4R mutations in adult populations from other countries have been reported 1 .  
 
The frequency of MC4R mutations observed in the present study is similar to values 
reported for obese children and adolescents from different European countries-Italy 18 
, France 19 , Germany 20 , the UK21  and Finland 22 - being the calculated mean 
mutation frequency of 2·94% (SE: 0·88).  
5 
10 
15 
20 
25 
Because discrepant results are reported in the literature concerning the presence of 
binge-eating disorder in MC4R mutation carriers, we performed face-to-face 
interviews with the aid of a BED questionnaire in 11 mutation carriers. None of the 
subjects fulfilled the diagnostic criteria for this eating disorder. Only the father of the 
index patient harbouring the Thr150Ile mutation, who transmitted the mutation, 
reported binge eating occasionally (twice a week).  
 
Assuming an inverse relationship between obesity and levels of physical activity 23 , 
and that the protective effect of physical activity for obesity development may depend 
on the genotype 24 , the present study sought to evaluate physical activity and 
sedentary behavior of MC4R mutation carriers.   
 
The Ser30Phe mutation of the MC4R gene was found in two obese subjects (male, 
aged 12 and female, aged 14). There are four known functional studies for the 
Ser30Phe variant itself, three in vitro assays established a normal receptor activity 20, 
25, 26 , but one demonstrated a lower response to the agonist 19  (Table 4). Concerning 
the family of the proband -carrier of the Ser30Phe mutation-, his father and his brother 
were both carriers and obese, even though they reported to spend more than 30 METS 
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hours/week in physical activities. This mutation was first found in a 15-year-old 
German obese adolescent who also harboured another mis-sense mutation 
(Gly252Ser) 14 . In German populations, at least four other Ser30Phe carriers have 
been reported: two obese children 20 , and two non-obese adults 1 . To our knowledge, 
this is the first time that this mutation usually associated with childhood obesity was 
found in a non-German population. 
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A novel nonsynonymous mutation of the MC4R gene consisting of the replacement of 
threonine for arginine at position 162 located in the 2nd intracellular loop of the MC4R 
was detected heterozygously in an overweight 13-year-old Spanish girl. All family 
members carrying the mutation were overweight or obese, while noncarriers were of 
normal weight. We have also conducted the first functional in vitro assay for the 
MC4R Thr162Arg mutation (Table 3). It appears that the mutated receptor had normal 
activity, while a slightly partial inactivation was found in maximal stimulation 
properties after the addition of α- or β-MSH agonist. Position 162 in the MC4R shows 
a high grade of conservation. Due to this condition, together with the fact that all 
experiments were conducted in an overexpression system using transient transfections, 
a significant influence of this mutation in vivo cannot be excluded. 
 
The Thr150Ile variant of the MC4R was first described and characterized by Vaisse et 
al.²9. It caused a decrease in receptor activation due to a reduction in receptor binding. 
Two recent studies also showed that this mutation modified not only the ability of the 
receptor to be activated by its ligand, but also its constitutive activity 3, 27 . In our 
Spanish population, two descendents of a father heterozygous for the Thr150Ile 
mutation (BMI=25.3 kg/m²) were also carriers of the mutation (one overweight and 
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one normal weight). Both carriers were physically active, spending more than 29.5 
METs hours/week in physical activities and little time in sedentary activities, (Fig. 1, 
family B). Similarly, the Ala244Glu mutation of the MC4R gene also impaired the 
receptor function in vitro, as reported in three published studies 19, 20, 26 . In our study, 
the proband harbouring this mutation was overweight and very active (65.6 METs 
hours/week). It is likely that high level of physical activity of these carriers have aided 
in their prevention of obesity.  
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In regard to the two MC4R polymorphisms, two children (one overweight boy and one 
obese girl) had the Val103Ile SNP and 11 subjects (seven boys) carried the Ile251Leu 
SNP of the MC4R gene (two obese, three overweight and six normal-weight subjects). 
The frequency of the Ile251Leu SNP in the obese group was 1.3%, with similar results 
in the overweight and normal-weight groups. A comparable value (2.5%) was 
obtained after the screening of a Spanish adolescent population from Santander 
(n=118, 48% males, age mean=15.5 years, BMI mean= 22.6 kg/m2) 28 . The observed 
values were similar to previous reports from other European countries: Germany 
(1.3%) 14,  and France (1.4%) 29 , which included subjects with severe childhood 
obesity and a family history of obesity. 
 
The Val103Ile polymorphism was detected in two subjects (one obese and one 
overweight). Similarly, the frequency in the Spanish adolescent population 
(Santander) was 0.8% 28 . In a number of studies, this variant was the most prevalent 
polymorphism of the MC4R receptor, associated with a decreased body weight 30 . In 
our Spanish population, the frequency of the Ile103 SNP is too low to support any 
conclusion. This also occurred with adult Spanish subjects 4 .  
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In summary, in our Spanish children and adolescents population we found one novel 
and three already known nonsynonymous mutations of the MC4R gene in 
heterozygous carriers. Specifically, an overweight subject (13-year-old girl) had the 
novel mutation Thr162Arg, which does not appear to alter in vitro receptor activity. 
Meanwhile, two overweight physically active subjects were carriers of mutations, 
which led to an impairment of the receptor function in vitro (Ala244Glu and 
Thr150Ile). A third mutation, Ser30Phe, was present in two obese children (14 and 12 
years old).  
 
We conclude that the presence of heterozygous MC4R mutations in obese and 
overweight subjects indicates that there may be a susceptibility factor for obesity 
development. Lifestyle factors, such as exercise or sedentary activities, may also 
modify this effect. 
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Table 1. Frequency of MC4R mutations and polymorphisms in 292 Spanish obese and overweight,  
children and adolescents 
 
Amino acid change Nucleotide 
substitution 
Obese Overweight Normal 
weight 
(n=159) 
(n=160) (n=132) 
Ser30Phe 89C>T 2 0 0 
Thr150Ile 449C>T 0 1 0 
Thr162Arg 485C>G 0 1 0 
Gly167Gly, silent 501G>A 1 0 0 
Ala244Glu 731C>A 0 1 0 
Val103Ile SNP 307G>A 1 1 0 
Ile251Leu SNP  751A>C 2 3 6 
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Table 2. Phenotypic characteristics of the Spanish children and adolescents population groups and MC4R gene mutation carriers 
 Obese Overweight Control Ser30Phe 
Ser30Phe 
(501G>A) 
Gly167Gly  Thr150Ile Thr162Arg Ala244Glu 
N n=160 n=132 n=159 Obese Obese Obese Overweight Overweight Overweight 
Age (yr) 11.4 (0.23) 11.7 (0.22) 11.8 (0.22) 14 12 11 16 13 15 
Sex (Female/Male) 83/77 67/65 79/81 Female Male Male Male Female Male 
Height (m) 1.50 (0.01) 1.49 (0.01) 1.50 (0.01) 1.62 1.57 1.55 1.82 1.51 1.71 
Actual weight (kg) 67.4 (1.69) 53.7 (1.27) 42.5 (1.07) 79.8 66.2 62.0 86.0 52.3 77.0 
BMI (kg/m2) 28.9 (0.4) 23.5 (0.2) 18.4 (0.2) 30.4 26.9 25.8 26.0 22.6 26.3 
BMI-SDS 4.35 (0.12) 1.99 (0.05) 0.04 (0.07) 3.54 3.39 3.36 1.56 2.48 1.84 
WHR 0.88 (0.007) 0.84 (0.008) 0.81 (0.005) NA 0.91 0.86 0.81 0.73 0.82 
% fat mass 36.9 (0.6) 28.3 (0.7) 17.0 (0.6) 42.1 31.7 39.8 14.3 34.1 22.2 
Glucose (mM) 4.95 (0.04) 4.87 (0.05) 4.64 (0.04) 4.72 4.94 5.00 5.38 5.22 NA 
Insulin (pmol/L) 113.3 (5.60) 75.9 (6.89) 47.2 (3.41) 76.8 57.6 47.4 36.0 47.4 NA 
TC (mM) 4.18 (0.07) 4.28 (0.07) 4.28 (0.07) 3.62 3.46 5.48 4.24 3.93 2.15 
TG (mM) 1.00 (0.05) 0.83 (0.05) 0.71 (0.03) 0.23 0.48 1.46 1.40 0.85 NA 
HDL (mM) 1.24 (0.03) 1.43 (0.04) 1.60 (0.03) 1.29 1.32 1.34 1.16 1.42 3.67 
LDL (mM) 2.59 (0.06) 2.55 (0.07) 2.35 (0.06) 1.99 1.94 3.49 2.46 2.12 1.63 
Leptin (ng/ml) 39.6 (1.66) 21.4 (1.49) 10.5 (0.94) 56.0 31.0 21.4 7.0 13.0 NA 
Cortisol (nmol/L) 425.0 (15.7) 436.1 (22.1) 419.5 (22.6) 276 336.7 171.1 297.2 NA NA 
METs-hours/week 18.2 (0.45) 27.6 (1.82) 37.3 (1.76) 10.1 13.1 26.2 29.5 NA 65.6 
Sedentary activities (h/week) 19.6 (0.97) 17.0 (1.03) 16.8 (0.91) 4.5 23.7 23.5 5 NA 4.5 
Hyperphagia    - + + + - + 
Values are mean (SD) when indicated. WHR, waist-to-hip ratio; TC, total cholesterol; TG, triglycerides; HDL, high density lipoprotein; LDL, low density 
lipoprotein; NA, no avalaible. Hyperphagia (+) was considered when they rated their appetite as a 5
 
Table 3. Functional assay for a novel non-synonymous (Thr162Arg) mutation in the MC4R gene   
  NDP-α-MSH α-MSH ß-MSH 
 Basal Max EC50 Max EC50 Max EC50 
Cell 
surface 
expr.  
Wild-type 1.00 1.00 
0.33±0.2
4 
1.00 2.0±0.58 1.00 6.0±1.7 100 
Thr162Arg 0.88±0.20 1.04±0.38 
0.86±0.5
2 
0.78±0.1
8 
1.5±0.75 0.8±0.17 6.6±3.4 97±15 
For functional characterization cAMP assays were performed as described in Materials and Methods. Max and EC50 values were determined from 
concentration-response curves of agonists (endogenous agonists 0.1 - 1000 nM, NDP-α-MSH 0.01 - 100 nM) using GraphPad Prism. Max values are 
given as percentage of maximum stimulation of the wild-type receptors. Data are presented as means ± SEM of five in duplicate performed independent 
experiments. Cell surface expression levels were measured by indirect cellular ELISA. Specific optical density (OD) readings (OD value of HA-tagged 
construct minus OD value of GFP-transfected cells) are given as percentage of wild-type HA-tagged MC4R. The nonspecific OD value (GFP) was 0.14 
± 0.04, and the OD value of the wild-type HA-tagged MC4R was 1.37 ± 0.29. ELISA data are given as mean ± SD of three independent experiments, 
each carried out in sextuple. 
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Table 4. Summary of some characteristics of the MC4R mutations according to the literature 
Membrane 
expression 
(%wt) 
Basal 
activity (% 
wt) 
Alpha-MSH EC50 
(fold over weight) 
Mutation Function Study 
Hinney et al.20  ND 140 0.45 Similar to wild type Ser30Phe 
Lubrano-Berthelier 
et al. 19  
>100 ND 1.98 Reduced response to agonist 
Santini et al. 25  ND ND Similar to wild type Similar to wild type 
Similar to wild 
type 
Xiang et al 26  ND 0.65 Similar to wild type 
Vaisse et al. 29  ND ND 23.9 Reduced response to agonist  Thr150Ile 
>100 <10 9.63 
Reduced basal function and 
response to agonist  
Lubrano-Berthelier 
et al.3  
>100 7 19.6 
Reduced basal function and 
response to agonist 
Govaerts et al. 27  
Xiang et al 26  ~60 ND 12.5 Reduced response to agonist 
Thr162Arg 97 ± 15 88 ± 20 Similar to wild type Similar to wild type This study 
ND 50 8.33 
Reduced basal function and 
response to agonist 
Hinney et al. 20  
Ala244Glu 
Lubrano-Berthelier 
et al.19  
90 ND 6.30 Reduced response to agonist 
Xiang et al. 26  ~70 ND 1.74 Reduced response to agonist 
ND, not determined 
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